Clinical Trial Update: Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating afamelanotide with NB-UVB phototherapy for nonsegmental vitiligo has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Afamelanotide (afamelanotide)
• Afamelanotide and NB-UVB Phototherapy
• NB-UVB phototherapy (narrowband UVB)

Snippet

Sponsor: Clinuvel Pharmaceuticals Limited | Conditions: Vitiligo | Phase 2 | Status: COMPLETED | Results posted: 2021-05-21